What is the projected market valuation of the Next-generation Cancer Diagnostic Market by 2035?

The market is projected to reach a valuation of 31.43 USD Billion by 2035. Read More

What was the market valuation of the Next-generation Cancer Diagnostic Market in 2024?

In 2024, the market valuation stood at 11.1 USD Billion. Read More

What is the expected CAGR for the Next-generation Cancer Diagnostic Market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 9.92%. Read More

Which technology segment is anticipated to have the highest growth in the Next-generation Cancer Diagnostic Market?

Next Generation Sequencing is expected to grow from 3.0 USD Billion in 2024 to 8.5 USD Billion by 2035. Read More

How does the market for Liquid Biopsy compare to other diagnostic technologies?

Liquid Biopsy is projected to grow from 1.8 USD Billion in 2024 to 5.0 USD Billion by 2035, indicating substantial growth. Read More

What are the leading applications in the Next-generation Cancer Diagnostic Market?

Leukemia is expected to dominate, growing from 3.6 USD Billion in 2024 to 10.0 USD Billion by 2035. Read More

Which end-user segment is likely to see the most significant growth in the Next-generation Cancer Diagnostic Market?

Diagnostic Centers are projected to expand from 3.33 USD Billion in 2024 to 10.31 USD Billion by 2035. Read More

What sample type is expected to have the highest market growth in the Next-generation Cancer Diagnostic Market?

Tissue Biopsies are anticipated to grow from 3.0 USD Billion in 2024 to 9.0 USD Billion by 2035. Read More

Who are the key players in the Next-generation Cancer Diagnostic Market?

Key players include Illumina, Thermo Fisher Scientific, Roche, and Guardant Health, among others. Read More

What trends are influencing the Next-generation Cancer Diagnostic Market?

The increasing demand for early cancer detection and advancements in genetic testing technologies are driving market growth. Read More

Next Generation Cancer Diagnostic Market

ID: MRFR/MED/32092-HCR

100 Pages

Rahul Gotadki

Last Updated: May 18, 2026

Next-generation Cancer Diagnostic Market Research Report: Size, Share, Trend Analysis By Technology (Genetic Testing, Liquid Biopsy, Immunoassays, Next Generation Sequencing, Radiomics), By Applications (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Leukemia), By End Users (Hospitals, Laboratories, Research Institutions, Diagnostic Centers), By Sample Type (Blood Samples, Tissue Biopsies, Urine Samples, Saliva Samples) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Next Generation Cancer Diagnostic Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Technology (USD Billion)
  1. 4.1.1 Genetic Testing
  2. 4.1.2 Liquid Biopsy
  3. 4.1.3 Immunoassays
  4. 4.1.4 Next Generation Sequencing
  5. 4.1.5 Radiomics
2. 4.2 Healthcare, BY Application (USD Billion)
  1. 4.2.1 Breast Cancer
  2. 4.2.2 Lung Cancer
  3. 4.2.3 Colorectal Cancer
  4. 4.2.4 Prostate Cancer
  5. 4.2.5 Leukemia
3. 4.3 Healthcare, BY End User (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Laboratories
  3. 4.3.3 Research Institutions
  4. 4.3.4 Diagnostic Centers
4. 4.4 Healthcare, BY Sample Type (USD Billion)
  1. 4.4.1 Blood Samples
  2. 4.4.2 Tissue Biopsies
  3. 4.4.3 Urine Samples
  4. 4.4.4 Saliva Samples
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Qiagen (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Guardant Health (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Exact Sciences (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Foundation Medicine (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Biocept (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 NantHealth (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 US MARKET ANALYSIS BY SAMPLE TYPE
7. 6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY END USER
10. 6.10 CANADA MARKET ANALYSIS BY SAMPLE TYPE
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY TECHNOLOGY
13. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION
14. 6.14 GERMANY MARKET ANALYSIS BY END USER
15. 6.15 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
16. 6.16 UK MARKET ANALYSIS BY TECHNOLOGY
17. 6.17 UK MARKET ANALYSIS BY APPLICATION
18. 6.18 UK MARKET ANALYSIS BY END USER
19. 6.19 UK MARKET ANALYSIS BY SAMPLE TYPE
20. 6.20 FRANCE MARKET ANALYSIS BY TECHNOLOGY
21. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION
22. 6.22 FRANCE MARKET ANALYSIS BY END USER
23. 6.23 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
24. 6.24 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
25. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
26. 6.26 RUSSIA MARKET ANALYSIS BY END USER
27. 6.27 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
28. 6.28 ITALY MARKET ANALYSIS BY TECHNOLOGY
29. 6.29 ITALY MARKET ANALYSIS BY APPLICATION
30. 6.30 ITALY MARKET ANALYSIS BY END USER
31. 6.31 ITALY MARKET ANALYSIS BY SAMPLE TYPE
32. 6.32 SPAIN MARKET ANALYSIS BY TECHNOLOGY
33. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION
34. 6.34 SPAIN MARKET ANALYSIS BY END USER
35. 6.35 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY TECHNOLOGY
42. 6.42 CHINA MARKET ANALYSIS BY APPLICATION
43. 6.43 CHINA MARKET ANALYSIS BY END USER
44. 6.44 CHINA MARKET ANALYSIS BY SAMPLE TYPE
45. 6.45 INDIA MARKET ANALYSIS BY TECHNOLOGY
46. 6.46 INDIA MARKET ANALYSIS BY APPLICATION
47. 6.47 INDIA MARKET ANALYSIS BY END USER
48. 6.48 INDIA MARKET ANALYSIS BY SAMPLE TYPE
49. 6.49 JAPAN MARKET ANALYSIS BY TECHNOLOGY
50. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION
51. 6.51 JAPAN MARKET ANALYSIS BY END USER
52. 6.52 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
57. 6.57 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
58. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
59. 6.59 MALAYSIA MARKET ANALYSIS BY END USER
60. 6.60 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
61. 6.61 THAILAND MARKET ANALYSIS BY TECHNOLOGY
62. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION
63. 6.63 THAILAND MARKET ANALYSIS BY END USER
64. 6.64 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
65. 6.65 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
66. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
67. 6.67 INDONESIA MARKET ANALYSIS BY END USER
68. 6.68 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
69. 6.69 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
70. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
71. 6.71 REST OF APAC MARKET ANALYSIS BY END USER
72. 6.72 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
75. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
76. 6.76 BRAZIL MARKET ANALYSIS BY END USER
77. 6.77 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
78. 6.78 MEXICO MARKET ANALYSIS BY TECHNOLOGY
79. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION
80. 6.80 MEXICO MARKET ANALYSIS BY END USER
81. 6.81 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
82. 6.82 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
83. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
84. 6.84 ARGENTINA MARKET ANALYSIS BY END USER
85. 6.85 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
99. 6.99 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
100. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
101. 6.101 REST OF MEA MARKET ANALYSIS BY END USER
102. 6.102 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.2.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.3.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.4.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.5.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.6.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.7.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.8.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.9.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.10.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.11.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.12.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.13.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.14.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.15.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.16.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.17.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.18.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.19.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.20.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.21.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.22.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.23.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.24.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.25.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.26.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.27.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.28.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.29.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion)
  4. 7.30.4 BY SAMPLE TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Technology (USD Billion, 2025-2035)

Genetic Testing
Liquid Biopsy
Immunoassays
Next Generation Sequencing
Radiomics

Healthcare By Application (USD Billion, 2025-2035)

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Leukemia

Healthcare By End User (USD Billion, 2025-2035)

Hospitals
Laboratories
Research Institutions
Diagnostic Centers

Healthcare By Sample Type (USD Billion, 2025-2035)

Blood Samples
Tissue Biopsies
Urine Samples
Saliva Samples

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”